Jubilant Life Sciences Overview

  • Founded
  • 1978
Founded
  • Status
  • Public
  • Employees
  • 36
Employees
  • Stock Symbol
  • 530019
Stock Symbol
  • Investments
  • 11
  • Share Price
  • $8.46
  • (As of Monday Closing)

Jubilant Life Sciences General Information

Description

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company with three business segments: Pharmaceuticals, Contract Research & Development Services and Proprietary Novel Drugs. Its Pharmaceuticals business is engaged in manufacturing and distribution of Radiopharmaceuticals; the Contract Research & Development Services provides innovation and collaborative research to global pharmaceutical innovators through two world-class research centers in Bengaluru and Noida in India. The proprietary novel drugs business is developing breakthrough therapies in the area of oncology and auto-immune disorders. The company generates a vast majority of its revenue in India with the remainder coming from the Americas, Europe, China, and other countries.

Contact Information

Formerly Known As
Vam Organic Chemicals
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
BOM
Primary Office
  • 1A, Sector 16A
  • Noida, Uttar Pradesh 201301
  • India
+91 0120 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jubilant Life Sciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.46 $8.31 $6.79 - $13.49 $1.33B 159M 29.7K $0.77

Jubilant Life Sciences Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 1,860,887 1,841,738 956,087 1,958,894
Revenue 980,305 801,597 822,351 1,285,435
EBITDA 256,473 199,998 231,426 209,988
Net Income 123,084 112,348 126,424 82,074
Total Assets 1,214,244 1,660,256 1,651,350
Total Debt 0 385,259 637,548 696,973
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jubilant Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jubilant Life Sciences‘s full profile, request access.

Request a free trial

Jubilant Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company with three business segments: Pharmaceuticals, Con
Pharmaceuticals
Noida, India
36 As of 2021
00000
0000 0000-00-00
00000000000 00000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000000000000
Bangalore, India
00000 As of 0000
000.00
0000 0000-00-00
00000000 000.00

00000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000 000000000
Mumbai, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jubilant Life Sciences Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocon Formerly PE-Backed Bangalore, India 00000 000.00 00000000 000.00
00000 Corporation Mumbai, India 00000 00000000
00000 000000 Corporation Ahmedabad, India 00000 00000000
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
00000000 000000 Corporation Mumbai, India 0000
You’re viewing 5 of 27 competitors. Get the full list »

Jubilant Life Sciences Patents

Jubilant Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019537597-A Synergistic antimicrobial composition Pending 07-Nov-2016 000000000
US-20190350200-A1 Synergistic antimicrobial compositions Abandoned 07-Nov-2016 000000000
EP-3534708-A1 Synergistic antimicrobial compositions Withdrawn 07-Nov-2016 000000000
US-10314312-B2 Synergistic antimicrobial composition of zinc pyrithione Active 27-Jun-2014 000000000
US-20170208815-A1 Synergistic antimicrobial composition of zinc pyrithione Granted 27-Jun-2014 A01N59/16

Jubilant Life Sciences Executive Team (21)

Name Title Board Seat Contact Info
Giuliano Perfetti Chief Executive Officer
Hari Bhartia Co-Chairman & Managing Director
Umesh Mehta Global Chief Information Officer & Executive Vice President
S. Sridhar Director
Sudha Pillai Director
You’re viewing 5 of 21 executive team members. Get the full list »

Jubilant Life Sciences Board Members (3)

Name Representing Role Since
0000 0000000 Jubilant Life Sciences Co-Chairman & Managing Director 000 0000
000000 00000 Jubilant Life Sciences Non-executive & Non-independent Director 000 0000
00000 0000000 Jubilant Life Sciences Chairman 000 0000
To view Jubilant Life Sciences’s complete board members history, request access »

Jubilant Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jubilant Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jubilant Life Sciences‘s full profile, request access.

Request a free trial

Jubilant Life Sciences Investments & Acquisitions (11)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 11-Nov-2020 00000 00000 00 0000 Drug Delivery
0000000 00000000 23-Dec-2014 000000000 000.00 Drug Delivery 0. 0000000000
0000 000000000 000 08-Jul-2010 000000000000000000 00.000 Industrial Chemicals 00000 0000000
0000000000 0000000 05-Aug-2008 0000000000 00.000 Multi-line Chemicals 00000 0000000
Draxis Health 28-May-2008 Merger/Acquisition 00000 Pharmaceuticals 0000000 0000000
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Jubilant Life Sciences Subsidiaries (3)

Company Name Industry Location Founded
Cadista Holdings Drug Delivery Salisbury, MD 1988
00000000 000000000 Other Consumer Products and Services 0000
00000000000000 000 Discovery Tools (Healthcare) Spokane, WA 0000
To view Jubilant Life Sciences’s complete subsidiaries history, request access »

Jubilant Life Sciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 19-Oct-1988 00000 0000000 Completed
  • 2 buyers
To view Jubilant Life Sciences’s complete exits history, request access »